Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center

Author:

Thibodeau StephaneORCID,Meem Mahbuba,Hopman Wilma,Sandhu Simran,Zalay Osbert,Fung Andrea S.,Kartolo Adi,Digby Geneviève C.,Al-Ghamdi Shahad,Robinson Andrew,Ashworth Allison,Owen Timothy,Mahmud Aamer,Tam Kit,Olding Timothy,de Moraes Fabio Ynoe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. South West Regional Cancer Program. (2013). How Are We Doing? – CSQ1 Data 2013. https://swrcpweb.lhsc.on.ca/sites/swrcpweb.lhsc.on.ca/files/CSQI_Data_2013_SWRCP.pdf.

2. Four-year survival with durvalumab after chemoradiotherapy in stage III NSCLC-an update from the PACIFIC trial;Faivre-Finn;J. Thorac. Oncol.,2021

3. Non-small-cell lung cancer with brain metastasis at presentation;Waqar;Clin. Lung Cancer,2018

4. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer;Peters;Cancer Treat. Rev.,2016

5. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more ``personalized’’ approach to cancer staging;Amin;CA Cancer J. Clin.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3